Skip to main content

Table 4 A description of the infectious complications in the postoperative period

From: Perioperative blood transfusion is associated with a gene transcription profile characteristic of immunosuppression: a prospective cohort study

Infection site

Number of episodes

Organisms

Median time to development of infection (days)

Bloodstream infection

11

Escherichia coli (4)

17 (6-28)

ESBL E. coli (1)

E. coli + Enterococcus faecium (1)

E. faecium (1)

Klebsiella pneumoniae (1)

Staphylococcus aureus (1)

Pseudomonas aeruginosa (2)

Pneumonia

9

Culture negative (5)

7 (4-16)

Candida glabrata (1)

K. pneumoniae (1)

Organism of the coliform group (1)

Stenotrophomonas maltophilia (1)

Wound infection

24

Culture negative (11)

10 (4-14)

Bacteroides fragilis (1)

E. coli (4),

ESBL E. coli (1)

Mixed anaerobes (1)

Organism of the coliform group (2)

Organism of the coliform group + E. faecalis (1)

Organism of the coliform group + MRSA (1)

Organism of the coliform group + S. aureus (1)

P. aeruginosa (1)

Urinary tract infection

15

Candida albicans (1)

8 (6-12)

Culture negative (2)

E. coli (6)

ESBL E. coli (1)

Mixed growth (2)

Organism of the coliform group (2)

P. aeruginosa (1)

Intra-abdominal infection

17

Culture negative (6)

9 (7-14)

E. coli (2)

E. coli + E. faecium (1)

ESBL E. coli + VRE (1)

E. faecalis (1)

E. faecium + Candida albicans (1)

C. albicans (1)

Enterobacter cloacae (1)

E. cloacae + Organism of the coliform group (1)

E. aerogenes + P. aeruginosa (1)

VRE (1)

Intravascular catheter- related infection

2

K. pneumoniae (1)

15 (3-27)

Organism of the coliform group (1)

Skin infection

1

Varicella zoster virus (VZV)

30

  1. Data refer to the number of episodes of infection from a particular site. Some patients may have more than one episode of infection. The number in parenthesis in the `organisms’ column the number of episodes of infection attributable to that organism. Data are described as median and interquartile range. ESBL, extended-spectrum beta-lactamase; MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant Enterococcus.